FDA Approves Merck’s RSV Vaccine for Infants to Compete with Sanofi-AstraZeneca
Merck’s Enflonsia: A New Hope Against RSV In a significant advancement for infant healthcare, the Food and Drug Administration (FDA) has granted approval for Merck’s Enflonsia, a monoclonal antibody treatment designed to protect infants from … Read more